pilocarpine has been researched along with triazoles in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doughty, MJ; Lyle, WM | 1 |
| Herzog, V; Miller, F | 1 |
| Geyer, O; Lazar, M; Loewenstein, A; Neudorfer, M; Shalmon, B | 1 |
| Carpineto, P; Ciancaglini, M; Gallenga, PE; Mastropasqua, L | 1 |
| Ebinger, G; Khan, GM; Michotte, Y; Smolders, I | 1 |
| Cavalheiro, EA; da Silva Fernandes, MJ; Doná, F; Ferreira, AT; Vianna, EP | 1 |
| Baraldi, PG; Fenu, S; Morelli, M; Simola, N; Tabrizi, MA | 1 |
| Brennum, LT; Chrobak, JJ; Collins, LE; Galtieri, DJ; Hinman, JR; Hockemeyer, J; Müller, CE; Sager, TN; Salamone, JD | 1 |
| Amorim, RP; de Oliveira, DM; Fernandes, MJ; Nehlig, A; Persike, DS; Rosim, FE | 1 |
| Brehme, H; Kirschstein, T; Köhling, R; Schulz, R | 1 |
| Ciruela, F; Fernández-Dueñas, V; Gandía, J; Morató, X; Stagljar, I | 1 |
| Bajorat, R; Goerss, D; Goßla, E; Kirschstein, T; Köhling, R; Kuhn, J; Porath, K; Sellmann, T | 1 |
1 review(s) available for pilocarpine and triazoles
| Article | Year |
|---|---|
A review of the clinical pharmacokinetics of pilocarpine, moxisylyte (thymoxamine), and dapiprazole in the reversal of diagnostic pupillary dilation.
Topics: Adrenergic alpha-Antagonists; Humans; Iris; Moxisylyte; Phenylephrine; Pilocarpine; Piperazines; Pupil; Triazoles; Tropicamide | 1992 |
1 trial(s) available for pilocarpine and triazoles
| Article | Year |
|---|---|
The additive miotic effects of dapiprazole and pilocarpine.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Miosis; Mydriasis; Ophthalmic Solutions; Parasympathomimetics; Phenylephrine; Pilocarpine; Piperazines; Pupil; Triazoles; Tropicamide | 1995 |
10 other study(ies) available for pilocarpine and triazoles
| Article | Year |
|---|---|
[The localization of endogenous peroxidase in the parotid gland of the rat].
Topics: Animals; Cytoplasmic Granules; Endoplasmic Reticulum; Golgi Apparatus; Histocytochemistry; Male; Microscopy, Electron; Microtomy; Parotid Gland; Peroxidases; Pilocarpine; Rats; Saliva; Spectrum Analysis; Triazoles | 1970 |
The usefulness of dapiprazole, an alpha-adrenergic blocking agent, in pigmentary glaucoma.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Muscarinic Agonists; Ophthalmic Solutions; Pilocarpine; Piperazines; Prospective Studies; Timolol; Treatment Outcome; Triazoles | 1996 |
Anticonvulsant effect and neurotransmitter modulation of focal and systemic 2-chloroadenosine against the development of pilocarpine-induced seizures.
Topics: 2-Chloroadenosine; Animals; Anticonvulsants; Behavior, Animal; Electroencephalography; Electrophysiology; Hippocampus; Injections; Male; Muscarinic Agonists; Neurotransmitter Agents; Pilocarpine; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Seizures; Triazoles | 2000 |
Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats.
Topics: 5'-Nucleotidase; Adenosine; Animals; Dentate Gyrus; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; In Situ Nick-End Labeling; Male; Neuronal Plasticity; Neuroprotective Agents; Pilocarpine; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Receptors, Purinergic P1; Status Epilepticus; Synapses; Triazoles; Xanthines | 2005 |
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
Topics: Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Jaw; Male; Movement; Parkinson Disease; Pilocarpine; Piperazines; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Tacrine; Tremor; Triazoles | 2006 |
Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Jaw; Male; Muscarinic Agonists; Pilocarpine; Pimozide; Pyrimidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Tremor; Triazoles; Xanthines | 2010 |
Differential neuroprotection by A(1) receptor activation and A(2A) receptor inhibition following pilocarpine-induced status epilepticus.
Topics: Adenosine; Analysis of Variance; Animals; Brain; Cell Count; Disease Models, Animal; Drug Interactions; Fluoresceins; Male; Nerve Degeneration; Neuroprotective Agents; Organic Chemicals; Phenylisopropyladenosine; Pilocarpine; Pyrimidines; Rats; Rats, Wistar; Reaction Time; Receptor, Adenosine A1; Receptor, Adenosine A2A; Status Epilepticus; Triazoles | 2011 |
In vivo treatment with the casein kinase 2 inhibitor 4,5,6,7- tetrabromotriazole augments the slow afterhyperpolarizing potential and prevents acute epileptiform activity.
Topics: Animals; Anticonvulsants; CA1 Region, Hippocampal; Casein Kinase II; Disease Models, Animal; Epilepsy, Temporal Lobe; Hydrocarbons, Brominated; Male; Membrane Potentials; Patch-Clamp Techniques; Pilocarpine; Rats; Rats, Wistar; Triazoles | 2014 |
Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.
Topics: Adenosine A2 Receptor Antagonists; Animals; Jaw; Male; Mice, Inbred C57BL; Mice, Knockout; Movement; Muscarinic Antagonists; Parkinsonian Disorders; Pilocarpine; Pyrimidines; Receptor, Adenosine A2A; Receptors, G-Protein-Coupled; Tremor; Triazoles; Tropicamide | 2015 |
Oral administration of the casein kinase 2 inhibitor TBB leads to persistent K
Topics: Administration, Oral; Animals; Anticonvulsants; CA1 Region, Hippocampal; Casein Kinase II; Disease Models, Animal; Electric Stimulation; Electroencephalography; Hydrocarbons, Brominated; Male; Maze Learning; Muscarinic Agonists; Neurotransmitter Agents; Pilocarpine; Potassium Channels, Calcium-Activated; Rats; Rats, Wistar; Status Epilepticus; Triazoles; Up-Regulation; Video Recording | 2018 |